It is not approved for human or veterinary use, and no therapeutic or performance claims are made for this formulation
In vitro and animal-model studies have examined its association with cytoskeletal organization, nitric-oxide-related signaling, angiogenesis-related mechanisms, and cellular adaptation under physiological stress
Contact Rift Phone/Text: 646-439-5550 Email: [email protected]
It is also important to note that products sold as AOD 9604 are often presented as injectable preparations, though some are marketed in oral or topical forms with unknown absorption and unverified quality
The 75mg dose should be administered via subcutaneous injection each morning, approximately 30 minutes before the first meal of the day
Once opened, most compounded tirzepatide vials remain stable for 28 to 42 days in the refrigerator, depending on the pharmacy specifications